Health Condition 1: null- Bioavalibility studty of Arsenic Trioxide in cancer patients
Conditions
Interventions
Intervention1: Arsenic trioxide (ATO) is ananticancer drug treatment for the treatment of Acute Promyelocytic Leukaemia (APL).: Ayurveda Practitioners also use oral Arsenic Trioxide (Somal) in wide ra
Sponsors
Rasayani Cancer Clinics Pune
Eligibility
Inclusion criteria
Inclusion criteria: 1. male or female cancer patient aged 20 to 70 years. 2.Cancer Patients who has expected survival of more than 3 months. 3.Cancer Patients who are not willing to take chemotherapy/eligible to take chemotherapy. 4.Cancer patients who are eligible to receive treatment of Somal. 5. Cancer patient who are willing to take ayurvedic treatment for cancer and provide consent for the same.
Exclusion criteria
Exclusion criteria: 1.Patients taking Chemotherapy 2.Patients taking conventional products containing Arsenic 3.Patient with deranged hepatic or renal profile at baseline. 4.Patients with Pre-existing cardiac illness Patients who has ECOG performance is > 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the bioavailability of Arsenic in patients consuming Somal.Timepoint: Day0, Day30, Day60, and Day90. | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Poonam Birari
Rasayu Cancer Clinic Pune.
Outcome results
None listed